Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Medicus Pharma Ltd. MDCX secured on Wednesday an exclusive, sublicensable global license from Pfizer Inc. PFE to develop, manufacture, and commercialize PF-08046031 (CD228V), an early clinical-stage ...

Pfizer Inc. stock (ISIN US7170811035) traded at USD 27.64 on September 17, 2026, with a market capitalization of USD 157.51 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

On September 3, a caller asked whether to rotate out of artificial intelligence stocks and add to Eli Lilly and Company (NYSE ...

Pfizer Inc. (NYSE: PFE) and Valneva SE (NASDAQ: VALN) reported on August 14 that the European Medicines Agency has validated ...

Pfizer Inc. has re-entered the obesity drug sector by acquiring Metsera, Inc., having successfully outmaneuvered six other bidders. Despite skepticism over Pfizer's recent acquisitions, Metsera's ...

Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 10:45 AM EDTCompany ParticipantsAlbert Bourla - Chairman of ...

NEW YORK-- (BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Alexandre de Germay, Chief International Commercial Officer, ...

At the close on September 14, 2026, Pfizer stock added a modest percent gain on the NYSE while the S&P 500 slipped, with ...

Pfizer Inc. closed 0.61% below its 52-week high of $28.75, which the company achieved on April 2nd. Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated ...